Nihon Kohden (OTCMKTS:NHNKY) Shares Down 4.5% – Should You Sell?

Nihon Kohden Corporation (OTCMKTS:NHNKY) shares were down 4.5% on Wednesday . The stock traded as low as $10.9625 and last traded at $10.9625. Approximately 688 shares were traded during trading, a decline of 97% from the average daily volume of 25,062 shares. The stock had previously closed at $11.48.

Analysts Set New Price Targets

Separately, UBS Group raised Nihon Kohden from a “hold” rating to a “strong-buy” rating in a research note on Monday, January 19th. One equities research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the stock has a consensus rating of “Strong Buy”.

Nihon Kohden Price Performance

The company has a 50-day simple moving average of $11.21 and a 200-day simple moving average of $11.37. The stock has a market cap of $1.88 billion, a PE ratio of 21.54 and a beta of 0.37.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings results on Thursday, February 5th. The company reported $0.16 earnings per share for the quarter. The business had revenue of $362.86 million for the quarter. Nihon Kohden had a net margin of 5.32% and a return on equity of 7.25%.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.